Brief: Clearmind Medicine Announces Positive Top-Line Results From First Cohort Of Its FDA-Approved Phase I/Iia Clinical Trial For Alcohol Use Disorder
18/11/2025 14:00
Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE ANNOUNCES POSITIVE TOP-LINE RESULTS FROM FIRST COHORT OF ITS FDA-APPROVED PHASE I/IIA CLINICAL TRIAL FOR ALCOHOL USE DISORDER CLEARMIND MEDICINE INC - CMND-100 SHOWS FAVORABLE SAFETY PROFILE WITH NO SERIOUS ADVERSE EVENTS Source text: ID:nGNX2810RG Further company coverage: CMND.O
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM